TP53 and esophageal cancer: High expression of the acidic nuclear phosphoprotein 32 (ANP32E) was observed in esophageal cancer (EC) and ANP32E−/−cells showed increased ferroptosis upon erastin treatment, associated with increased p53-mediated SLC7A11 downregulation [183].